These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 1325358)

  • 1. Sensitivity to μ-opioid receptor-mediated anti-nociception is determined by cross-regulation between μ- and δ-opioid receptors at supraspinal level.
    Ballesta JJ; Cremades J; Rodríguez-Muñoz M; Garzón J; Faura CC
    Br J Pharmacol; 2012 May; 166(1):309-26. PubMed ID: 22023056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.
    Shippenberg TS; LeFevour A; Chefer VI
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):442-53. PubMed ID: 19128202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.
    Shippenberg TS; Chefer VI; Thompson AC
    Biol Psychiatry; 2009 Jan; 65(2):169-74. PubMed ID: 18950747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice.
    Thongpradichote S; Matsumoto K; Tohda M; Takayama H; Aimi N; Sakai S; Watanabe H
    Life Sci; 1998; 62(16):1371-8. PubMed ID: 9585164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats.
    Kitchen I; Pinker SR
    Br J Pharmacol; 1990 Aug; 100(4):685-8. PubMed ID: 2169936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
    Crook TJ; Kitchen I; Hill RG
    Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociception after intracerebroventricular administration of naltrindole in the mouse.
    Stapelfeld A; Hammond DL; Rafferty MF
    Eur J Pharmacol; 1992 Apr; 214(2-3):273-6. PubMed ID: 1325358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational drug design of selective epsilon opioid receptor agonist TAN-821 and antagonist TAN-1014.
    Fujii H; Nagase H
    Curr Med Chem; 2006; 13(10):1109-18. PubMed ID: 16719773
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.